Related references
Note: Only part of the references are listed.Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
Mohammad Zarei et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Jorn M. Schattenberg et al.
JOURNAL OF HEPATOLOGY (2021)
Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling
Yingyan Wang et al.
CELL DEATH & DISEASE (2021)
Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
Anita M. van den Hoek et al.
SCIENTIFIC REPORTS (2021)
Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
Menso J. Westerouen Van Meeteren et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Adaptive immunity: an emerging player in the progression of NAFLD
Salvatore Sutti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
Mohammad Zarei et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness
Yanan Li et al.
ONCOIMMUNOLOGY (2020)
S100A4 as a Target of the E3-Ligase Asb2 beta and Its Effect on Engineered Heart Tissue
Simon Braumann et al.
FRONTIERS IN PHYSIOLOGY (2018)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies
Fei Fei et al.
CELL AND BIOSCIENCE (2017)
Metastasis regulation by PPARD expression in cancer cells
Xiangsheng Zuo et al.
JCI INSIGHT (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
John C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
S100A4 promotes liver fibrosis via activation of hepatic stellate cells
Lin Chen et al.
JOURNAL OF HEPATOLOGY (2015)
Establishing the Role of PPARβ/δ in Carcinogenesis
Jeffrey M. Peters et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism
Laia Salvado et al.
DIABETOLOGIA (2014)
Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer
Alexandra Montagner et al.
EMBO MOLECULAR MEDICINE (2014)
Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN-45 gastric carcinoma cells
Mitsumasa Tsuchiya et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Phosphorylation of serine 323 of ASB2α is pivotal for the targeting of filamin A to degradation
Rim Zakaria et al.
CELLULAR SIGNALLING (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Sulfiredoxin Redox-Sensitive Interaction with S100A4 and Non-Muscle Myosin IIA Regulates Cancer Cell Motility
Robert R. Bowers et al.
BIOCHEMISTRY (2012)
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
Radina Kostadinova et al.
CELL AND BIOSCIENCE (2012)
Two Functional S100A4 Monomers Are Necessary for Regulating Nonmuscle Myosin-IIA and HCT116 Cell Invasion
Reniqua P. House et al.
BIOCHEMISTRY (2011)
The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
Emma Barroso et al.
ENDOCRINOLOGY (2011)
Markers of Monocyte Activation Revealed by Lipidomic Profiling of Arachidonic Acid-Containing Phospholipids
David Balgoma et al.
JOURNAL OF IMMUNOLOGY (2010)
Phenothiazines inhibit S100A4 function by inducing protein oligomerization
Vladimir N. Malashkevich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Manu V. Chakravarthy et al.
CELL (2009)
The E3 ubiquitin ligase specificity subunit ASB2β is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation
N. F. Bello et al.
CELL DEATH AND DIFFERENTIATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
ASB2 targets filamins A and B to proteasomal degradation
Melina L. Heuze et al.
BLOOD (2008)
Activation of peroxisome proliferator-activated receptor β/δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-κB activity via extracellular signal-related kinase 1/2
Ricardo Rodriguez-Calvo et al.
DIABETES (2008)
Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease
Karolina A. Rygiel et al.
LABORATORY INVESTIGATION (2008)
Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice
Weiwei Shan et al.
HEPATOLOGY (2008)
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition
Michael Zeisberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hepatic histology in obese patients undergoing bariatric surgery
Mariana Machado et al.
JOURNAL OF HEPATOLOGY (2006)
Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β/δ
K Nadra et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
S100A4, a mediator of metastasis
SC Garrett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Calcium-dependent and -independent interactions of the S100 protein family
Liliana Santamaria-Kisiel et al.
BIOCHEMICAL JOURNAL (2006)
The metastasis associated protein S100A4: role in tumour progression and metastasis
DM Helfman et al.
BRITISH JOURNAL OF CANCER (2005)
Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
T Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells
K Hellemans et al.
GASTROENTEROLOGY (2003)
Share Paper
